同期鼻中隔鼻成形术与内镜鼻窦手术的生活质量改善
本研究前瞻性评估了因慢性鼻窦炎行单纯内镜鼻窦手术(n=57)、单纯鼻中隔鼻成形术(n=148)及同期联合手术(n=62)患者术前与术后1年的疾病特异性生活质量。三组术后生活质量均显著改善(均p<0.01),联合手术组改善幅度略小于单手术组。作者认为,在适用情况下,术者可提供联合手术的获益而不影响生活质量的改善。
要点
- 单纯内镜鼻窦手术、单纯鼻中隔鼻成形术及同期联合手术均可显著改善疾病特异性生活质量(均p<0.01)。
- 联合手术组术后ROE改善略小于单手术组(联合+55.2±9.3 vs 单手术+58.8±9.8,p=0.02)。
- 作者认为,在适用情况下,术者可提供联合手术的获益而不影响生活质量的改善。
核心结论
- 鼻中隔鼻成形术、内镜鼻窦手术及联合手术均改善疾病特异性生活质量。
- 作者认为,在适用情况下,术者可提供联合手术的获益而不影响生活质量的改善。
研究设计与样本
- 前瞻性评估因慢性鼻窦炎行单纯内镜鼻窦手术(n=57)、单纯鼻中隔鼻成形术(n=148)及同期联合手术(n=62)的患者。
- 所有手术均由同一术者(OCB)完成。
- 术前及术后1年评估疾病特异性生活质量,鼻中隔鼻成形术采用ROE和FROI-17,慢性鼻窦炎采用SNOT22。
主要发现
- 三组术后生活质量测量均显著改善(均p<0.01)。
- ROE改善:联合手术组+55.2±9.3 vs 单手术组+58.8±9.8(p=0.02)。
- FROI总分改善:联合手术组+47.6±5.2 vs 单手术组+49±5.4(p=0.08)。
- SNOT22改善:联合手术组+33.1±6.7 vs 单手术组+34.5±7(p=0.26)。
关键数值与推荐
- ROE改善:联合手术组+55.2±9.3 vs 单手术组+58.8±9.8(p=0.02)。
- FROI总分改善:联合手术组+47.6±5.2 vs 单手术组+49±5.4(p=0.08)。
- SNOT22改善:联合手术组+33.1±6.7 vs 单手术组+34.5±7(p=0.26)。
临床怎么用
- 作者认为,在适用情况下,术者可提供联合手术的获益而不影响生活质量的改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Septorhinoplasty (SRPL) and functional endoscopic sinus surgery (FESS) are two frequently performed surgeries to improve quality of life (QoL) in patients with nasal symptoms. It has been demonstrated as a safe combination regarding complication rates, but patient satisfaction in concurrent surgery has not been adequately studied yet. METHODS: Patients undergoing sole FESS due to chronic rhinosinusitis (n = 57), sole SRPL (n = 148), and concurrent surgery (n = 62) were prospectively evaluated for their disease-specific QoL before and one year after surgery. Each procedure was performed by the same surgeon (OCB). For SRPL, the patient-reported outcome measures Rhinoplasty Outcomes Evaluation (ROE) and Functional Rhinoplasty Outcome Inventory (FROI-17) were utilized, and for chronic rhinosinusitis, the Sino-Nasal Outcome Test-22 (SNOT22). RESULTS: All three groups showed significant improvement in the postoperative QoL measurements (all p < 0.01). The postoperative improvements were slightly smaller in the concurrent surgery group compared with the single surgery groups measured with ROE (combined: +55.2 ± 9.3, single: +58.8 ± 9.8, p = 0.02), FROI total score (combined: +47.6 ± 5.2, single: +49 ± 5.4; p = 0.08) and SNOT22 (combined: +33.1 ± 6.7, single +34.5 ± 7, p = 0.26). CONCLUSIONS: SRPL, FESS, and combined surgery improve disease-specific QoL. When applicable, surgeons may offer the benefits of a combined procedure without compromising the QoL gain. LEVEL OF EVIDENCE: 3 Laryngoscope, 134:1239-1245, 2024.
引用
- Bulut OC, Lippert BM, Riedel F, et al. Quality of Life Improvement in Concurrent Septorhinoplasty and Endoscopic Sinus Surgery. Laryngoscope. 2023. PMID: 37706653. doi:10.1002/lary.31054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。